Clinical Trial Update: Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC) [Phase 1, Phase 2]

View source ↗

Summary

This document reports an ongoing Phase 1/2 clinical trial evaluating palbociclib in combination with bicalutamide for androgen receptor–positive metastatic brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)
• bicalutamide (bicalutamide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Breast Cancer (MBC) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING